NAS:NVCR (Jersey)  
NovoCure Ltd logo

NovoCure Ltd

$ 78.21 +2.23 (+2.93%) 10:10 AM EST
P/E:
At Loss
P/B:
18.71
Market Cap:
$ 8.26B
Enterprise V:
$ 7.97B
Volume:
60.25K
Avg Vol (2M):
443.76K
Also Trade In:
Volume:
60.25K
Market Cap $:
8.26B
PE Ratio:
At Loss
Avg Vol (2-Month):
443.76K
Enterprise Value $:
7.97B
PB Ratio:
18.71
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.64
Equity-to-Asset 0.38
Debt-to-Equity 1.31
Debt-to-EBITDA -13.36
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.07
Distress
Grey
Safe
Beneish M-Score -2.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.72
9-Day RSI 39.83
14-Day RSI 42.6
6-1 Month Momentum % -0.87
12-1 Month Momentum % -29.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.08
Quick Ratio 7.87
Cash Ratio 7.01
Days Inventory 83.22
Days Sales Outstanding 63.82
Days Payable 212.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.7

Financials (Next Earnings Date:2022-10-28 Est.)

NVCR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NVCR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 545.232
EPS (TTM) ($) -0.65
Beta 0.44
Volatility % 43.27
14-Day RSI 42.6
14-Day ATR ($) 3.67386
20-Day SMA ($) 81.4125
12-1 Month Momentum % -29.3
52-Week Range ($) 56.39 - 124.35
Shares Outstanding (Mil) 104.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NovoCure Ltd Filings

Document Form Filing Date
No Filing Data

NovoCure Ltd Analysis

Share your research

Headlines

See More
No news.